| Disease-free survival | Overall survival | ||
---|---|---|---|---|
 | HR (95%CI) | P-value | HR (95%CI) | P-value |
Molecular subtyping | Â | Â | Â | Â |
   IHC-BLBC | 1.00 |  | 1.00 |  |
   IHC-QNBC/5NP | 1.43 (0.84-2.45) | 0.188 | 1.20 (0.65-2.22) | 0.558 |
Tumor size (cm) | Â | Â | Â | Â |
   ≤ 2 cm | 1.00 |  | 1.00 |  |
   2-5 cm | 1.44 (0.76-2.73) | 0.258 | 1.61 (0.75-3.46) | 0.219 |
   > 5cm | 3.06 (1.27-7.35) | 0.012 | 4.07 (1.56-10.5) | 0.004 |
LN involvement | Â | Â | Â | Â |
   Negative | 1.00 |  | 1.00 |  |
   Positive | 2.54 (1.44-4.48) | 0.001 | 3.83 (1.92-7.65) | < 0.001 |
Adjuvant Chemotherapy | Â | Â | Â | Â |
   Not done | 1.00 |  | 1.00 |  |
   Done | 0.54 (0.23-1.28) | 0.161 | 0.31(0.13-0.76) | 0.011 |